Enliven Therapeutics, Inc (ELVN) Tops Q3 EPS by 3c

Enliven Therapeutics, Inc (NASDAQ: ELVN) reported Q3 EPS of ($0.48), $0.03 better than the analyst estimate of ($0.51).

For earnings history and earnings-related data on Enliven Therapeutics, Inc (ELVN) click here.

You May Also Be Interested In

• Tesla to launch Cybercab in Austin this month - report
• XP Inc eyes US banking license as next business step
• Duos Technologies Group, Inc. (DUOT) Tops Q2 EPS by 163c